Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2959 of 5804
-
Can diet and exercise programs cut cancer risk? new study tests lifestyle changes
Prevention OngoingThis pilot clinical trial studies different types of energy balance interventions to see how well they work in increasing the physical activity levels of breast cancer gene-positive patients, Lynch syndrome-positive patients, chronic lymphocytic leukemia (CLL) survivors or family…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
New hope for dialysis patients with blocked chest veins
Disease control CompletedThe treatment objective for patients with SVC syndrome secondary to both malignant and benign etiologies is to reduce the elevated central venous pressures.1 However, the strategies are contingent upon the underlying disease process. Thus the management of SVC syndrome ranges fro…
Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a cancer drug beat CLL fatigue? small trial hopes to find out
Symptom relief OngoingThis phase II trial studies how well ruxolitinib phosphate works in reducing fatigue in patients with chronic lymphocytic leukemia. Ruxolitinib phosphate may stop the growth of cancer cells by blocking a protein called Janus kinase (JAK) that is needed for cell growth and may als…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Global krabbe disease registry aims to decode early warning signs
Knowledge-focused Recruiting nowThe purpose of this study is to develop a clinical database of individuals diagnosed with Krabbe disease in order to determine which symptoms herald the onset of clinical disease in the various phenotypes of Krabbe disease; to determine whether level of GALC enzyme activity, or a…
Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Could less radiation be safer for kids with neuroblastoma?
Disease control CompletedThe purpose of this study is to give 12T a smaller dose of radiation in order to decrease these late side effects.
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Massive study tests diabetes drug for heart attack recovery
Knowledge-focused OngoingThis observational, retrospective cohort study aims to evaluate the impact of sodium-glucose cotransporter 2 (SGLT2) inhibitor use after acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM). Using the nationwide database from the Korean National Heal…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New drug combo shows promise for tough ovarian cancer
Disease control CompletedThe purpose of this study is to find out if a new drug, LDE225, is safe and has beneficial effects when combined with paclitaxel in women with platinum resistant ovarian cancer. Platinum resistant ovarian cancer refers to recurrent ovarian cancer that has undergone chemotherapy i…
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo attack on liver cancer: drug activated by Tumor's own hypoxia
Disease control Recruiting nowThis phase 1 study is to determine the optimal dose and tolerability of a hypoxia-activating agent, tirapazamine, when it is combined with embolization in liver cancer. Liver cancer patients who are Child-Pugh score A, suitable for embolization with tumor no more than 4 nodules a…
Phase: PHASE1, PHASE2 • Sponsor: Teclison Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Zap to see: electrical therapy for eye disease
Symptom relief OngoingMeasures of vision in RP patients receiving promising therapy using transcorneal electrical stimulation.
Phase: NA • Sponsor: Nova Southeastern University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Scientists hunt for eye disease genes in 2,000-Person study
Knowledge-focused Recruiting nowObjective: The objective of this study is to identify genetic causes of inherited eye conditions through whole exome or whole genome sequencing (referred to as exome sequencing and genome sequencing in the remainder of the document). This includes identifying mutations in known g…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New radiation approach targets multiple tumors at once in early trial
Knowledge-focused CompletedThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or prostate cancer that has spread to other parts of the body. Stereotactic body radiation therapy delivers fe…
Phase: PHASE1 • Sponsor: NRG Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New combo pill shows promise for diabetes control over one year
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of co-administration of Teneligliptin (MP-513) and Canagliflozin (TA-7284) once daily for 52 weeks in Japanese patients with Type 2 diabetes mellitus who are receiving treatment with Teneligliptin and have inadequat…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Brain games for young cancer survivors: a promising pilot study
Symptom relief CompletedThis randomized clinical trial studies how well an adaptive computerized cognitive training program works compared to a non-adaptive computerized cognitive training program in treating younger patients with brain tumor who underwent radiation therapy. Providing a computer trainin…
Phase: NA • Sponsor: Children's Oncology Group • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Testicular cancer survivors face hidden heart risks – study seeks answers
Knowledge-focused OngoingTesticular cancer (TC) is a rare disease, which mostly affects young men aged 15-35 years. Their life expectancy has greatly improved due to the introduction of platinum-containing chemotherapy for disseminated TC in the late 1970s. Given the good prognosis of TC nowadays, preven…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:01 UTC
-
Brain-Computer training eases stroke arm stiffness
Symptom relief CompletedThis study examines whether in-lab training with a myoelectric-computer interface (MyCI) can reduce abnormal muscle co-activation after stroke.
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could a common gut drug help you heal faster after surgery?
Disease control CompletedHypothesis: Prucalopride can mimic electrical stimulation of the abdominal vagus nerve and has an anti-inflammatory effect. Aims: In the present pilot study, the investigators want to evaluate the anti-inflammatory effect of prucalopride. The following aims are formulated: 1.…
Phase: PHASE4 • Sponsor: KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug cocktail shows promise in Hard-to-Treat cancers
Disease control CompletedThis phase I trial studies the side effects and best dose of sapanisertib and ziv-aflibercept in treating patients with solid tumors that have come back (recurrent) and have spread to another place in the body (metastatic) or cannot be removed by surgery (unresectable). Sapaniser…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
2000 patients to fuel breast cancer discoveries
Knowledge-focused Recruiting nowThis study is being done to create a resource of samples and information that can be used to improve our understanding of the development, progression and treatment of recurrent or metastatic breast cancer or male breast cancer.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Learning to live well: education program boosts heart and stroke recovery
Disease control CompletedThe Exploration Center for Prevention and Treatment of Atherosclerosis (CEPTA, Bordeaux Hospital University) showed that following myocardial infarct (MI) or ischemic stroke (TIA or stroke), the global management (medical and educational) of patients led to very long-term satisfa…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a statin and arthritis drug tame childhood brain cancer?
Disease control CompletedOptico-chiasmatic gliomas have therapeutic feature since surgical resection plays a secondary role. Unlike other sites, many of these tumors are not amenable to complete resection either because of anatomical location, and sometimes they only can be biopsied. A substantial number…
Phase: PHASE1 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC